Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-23-006994

Director acquired 53,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HERSHBERG ROBERT Director 2023-02-02 Option exercise +53,000 $0.45 $23,850 61,193 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HERSHBERG ROBERT Director 2023-02-02 Option exercise · Stock Option (Right to Buy) −53,000 0 D: show line 2 in the form
Loading xslF345X03/doc4.xml…